PharmAust: New Drug Entering Phase 2 Trials Targeting Multiple Cancers

Interview on RedChip Money Report television program aired on Bloomberg the 2nd and 3rd of January 2016

PharmAust: Developing Targeted Cancer Therapy

Dave Gentry, host of “The RedChip Money Report”, interviews Dr. Roger Aston, Executive Chairman of PharmAust Ltd (ASX: PAA) as aired on Bloomberg​​ TV.

PharmAust Presentation at RedChip’s February 2016 Conference

PharmAust presentation at the RedChip Global Online Microcap Conference on Thursday, February 11, 2016.